Alzheimer's Research & Therapy

Figure 1 | Alzheimer's Research & Therapy

Figure 1

From: Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trial

ISSN: 1758-9193

Contact us

General enquiries: journalsubmissions@springernature.com